FierceBiotech ٢٥ مارس ٢٠٢٦ BrightGene's oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
FierceBiotech ٢٥ مارس ٢٠٢٦ Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech ٢٤ مارس ٢٠٢٦ Medtronic, Biotronik heart hardware make strides in conduction system pacing
FierceBiotech ٢٤ مارس ٢٠٢٦ Shionogi pays Apnimed $100M for joint venture to awaken sleep disorder dream
FierceBiotech ٢٤ مارس ٢٠٢٦ Ocugen eye disease gene therapy hits ph. 2 targets but underwhelms investors
FierceBiotech ٢٤ مارس ٢٠٢٦ Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos
FierceBiotech ٢٤ مارس ٢٠٢٦ Aardvark halts trials of obesity candidate, putting entire pipeline on pause
FierceBiotech ٢٤ مارس ٢٠٢٦ Innovent sees path to China approval after eye disease drug matches Eylea in phase 3
FierceBiotech ٢٣ مارس ٢٠٢٦ Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
FierceBiotech ٢٣ مارس ٢٠٢٦ Sanofi returns to T-cell engager territory with $1.2B pact for phase 1-stage trispecific
FierceBiotech ٢٣ مارس ٢٠٢٦ FDA solicits feedback on controversial national priority voucher review pathway
FierceBiotech ٢٣ مارس ٢٠٢٦ Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
FierceBiotech ٢٣ مارس ٢٠٢٦ Stryker continues to bring hacked systems back online after patients delay surgeries